Leishmania major-Phlebotomus duboscqi interactions: Inhibition of anti-LPG antibodies and characterisation of two proteins with shared epitopes

East African Medical Journal

Volumn 81, Issue 2, 2004, Pages 97-103

  Tonui, W K ^a   Ngumbi, P M ^a   Mpoke, S S ^a   Orago, A S ^b   Mbati, P A ^c   Turco, S J ^d   Mkoji, G M ^a  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b KENYATTA UNIVERSITY   (Kenya)

^c UNIVERSITY OF LIMPOPO   (South Africa)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GLYCOSPHINGOLIPID; LIPOPHOSPHOGLYCAN; MONOCLONAL ANTIBODY; PARASITE ANTIGEN;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; DISEASE CARRIER; GROWTH, DEVELOPMENT AND AGING; HOST PARASITE INTERACTION; IMMUNOLOGY; LEISHMANIA MAJOR; MOUSE; PARASITOLOGY; PHLEBOTOMUS; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PROTOZOAN; EPITOPES; GLYCOSPHINGOLIPIDS; HOST-PARASITE RELATIONS; INSECT VECTORS; LEISHMANIA MAJOR; MICE; MICE, INBRED BALB C; PHLEBOTOMUS;

EID: 2342478619     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Solbach, W. and Laskay, T. The host response to Leishmania infection. Adv. Immunol. 2000; 74:275-317.
2. Lawyer, P.G., Ngumbi, P.M., Anjili, C.O., et al. Development of Leishmania major and Sergentomyia schwetzi (Diptera: Psychodidae). J. Amer. Trop. Med. and Hyg. 1990; 43:31-43.
3. McConville, M.J. and Ferguson, M.A. The structure, biosynthesis and function of glycosylated phosphatidylinositols in the parasitic protozoa and higher eukaryotes. Biochem. J. 1993; 294:305-324.
4. Lohman, K.L., Langer, P.J. and McMahon-Pratt, D. Molecular cloning and characterisation of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis. Proc. Nat. Acad. Sci. 1990; 87:8393-8397.
5. Turco S.J., and Descoteaux, A. The lipophosphoglycan of Leishmania parasites. Ann. Rev. Microbiol. 1992; 46:65-94.
6. Pimenta, P.F.P., Saraiva, M.B., Rowton, E., et al. Evidence that vectorial competence of Phlebotomine sand flies from different species of Leishmania is controlled by structural polymorphisms in the surface lipophosphoglycan. Proc. Nat. Acad. Sci. USA. 1994; 91:9155-9159.
7. Butcher, B.A., Turco, S.J., Hilly, B.A., et al. Deficiency in. 1,3-Galactosyl transferase of a Leishmania major LPG Mutant adversely influences the Leishmania-sand fly interaction. J. Biol. Chem. 1996; 271:20573-20579.
8. Tonui, W.K. Leishmania transmission-blocking vaccines: a review. East. Afr. Med. J. 1999; 76:93-96.
9. Anjili, C.O., Mbati, P.A., Ngumbi, P.M., Lugalya, R.M. and Githure, J.I. Effects of feeding Phlebotomus duboscqi on different anti-Leishmania monoclonal antibodies on development of Leishmania major. (2002 In Press.)
10. Tolson, D.L., Turco, S.J., Beecroft, R.P. and Pearson, T.W. The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol. Biochem. Parasitol. 1989; 35:109-118.
11. Kohler, G. and Milstein, C. Continous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256:497.
12. Kennett, R.H., Denis, K.A., Tung, A.S. and Klinman, N.R. Hybrid plasmacytoma production: fusion with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells. Curr. Topics in Microbiol. Immunol. 1978, 81:77.
13. Beach, R., Young, D.G. and Kiilu, G. New Phlebotomine sand fly colonies II. Laboratory colonisation of Phlebotomus duboscqi (Diptera: Psychodidae). J. Med. Entomol. 1986; 23:114-115.
14. Chulay, J.D. and Brycesson, A.D.M. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Amer. J. Trop. Med. Hyg. 1983; 32:475-479.
15. Laemli, U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227:680-685.
16. Towbin, H., Stachelin, T. and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide amide gels to nitrocellulose sheets. Procedure and some applications. Proc. Nat. Acad. Sci. 1979; 76:4350-4354.
17. Ng, K., Handman, E. and Basic A., Biosynthesis of lipophosphoglycan from Leishmania major: solubilisation and characterisation of a (beta 1-3) galactosyltransferase. Biochem. J. 1996; 317:247-255.
18. Hunter, K.W. Jr, Cook, C.L., and Hensen, S.A. Temperature-induced in vitro transformation of Leishmania mexicana. I. Ultrastructural comparison of culture-transformed and intracellular amastigotes. Acta Tropica. 1982; 39:143-150.
19. Doherty, T.M. and Coffman, R.L. Leishmania major: Effect of infectious dose on T cell subset development in BALB/c mice. Exp. Parasitol. 1996; 84:124-135.
20. Sacks, D.L., Modi, G., Rouston, E. et al. The role of phosphoglycans in Leishmania-sand fly interactions. Proc. Nat. Acad. Sci. 2000; 97:406-411.
21. Herman, R. Cytophilic and opsonic antibodies in visceral leishmaniasis in mice. Infect. Imm. 1980; 28:585-593.
22. Anderson, S., David, J.R. and McMahon-Pratt D. In vivo protection against Leishmania mexicana mediated by monoclonal antibodies. J. Immunol. 1983; 131:1616-1618.
23. Monjour, L., Vouldoukis, I., Debons-Guillemin, M.C., et al. Application of an in vivo culture system for rapid demonstration of anti-Leishmania activity of monoclonal antibodies. Trans. Roy. Soc. Trop. Med. Hyg. 1987; 81:210-211.
24. Ramasamy, M.S., and Ramasamy, R. Effect of anti-mosquito antibodies on the infectivity of the rodent malaria parasite Plasmodium berghei to Anopheles farauti. Med. Vet. Entomol. 1990; 4:161-166.
25. Kelleher, M., Curtis, J.M., Sacks, D.L., Handman, E. and Basic, A. Epitope mapping of monoclonal antibodies directed against lipophosphoglycan of Leishmania major promastigotes. Mol. Biochem. Parasitol. 1994; 66:187-200.
26. Mbati, P.A., Anjili, C.O., Lugalia, R., et al. Experimental immunisation against cutaneous leishmaniasis using Leishmania major subcellular fractions alone or in combination with Phlebotomus duboscqi gut antigens. East Afr. Med. J. 1995; 72:519-522.